Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- AI Summary
- About
USANA Health Sciences Inc (USNA)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/14/2025: USNA (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -24.83% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance 2.0 | Stock Returns Performance 1.0 |
Profits based on simulation | Last Close 01/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 639.45M USD | Price to earnings Ratio 11.86 | 1Y Target Price 51.5 |
Price to earnings Ratio 11.86 | 1Y Target Price 51.5 | ||
Volume (30-day avg) 116815 | Beta 0.89 | 52 Weeks Range 31.44 - 52.75 | Updated Date 01/14/2025 |
52 Weeks Range 31.44 - 52.75 | Updated Date 01/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 2.83 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 6.3% | Operating Margin (TTM) 7.79% |
Management Effectiveness
Return on Assets (TTM) 8.09% | Return on Equity (TTM) 10.83% |
Valuation
Trailing PE 11.86 | Forward PE 11 | Enterprise Value 321200043 | Price to Sales(TTM) 0.74 |
Enterprise Value 321200043 | Price to Sales(TTM) 0.74 | ||
Enterprise Value to Revenue 0.37 | Enterprise Value to EBITDA 2.82 | Shares Outstanding 19059600 | Shares Floating 9955767 |
Shares Outstanding 19059600 | Shares Floating 9955767 | ||
Percent Insiders 41.71 | Percent Institutions 57.65 |
AI Summary
USANA Health Sciences Inc. (USNA): A Comprehensive Overview
Company Profile:
Detailed history and background: USANA Health Sciences Inc. (USNA) was founded in 1992 by Myron Wentz. The company started as a multi-level marketing (MLM) business selling nutritional supplements and personal care products. Today, USANA still operates through a network of independent distributors in over 20 countries. However, the company also sells its products through its website and retail stores.
Core business areas: USANA's core business is the development, manufacturing, and distribution of nutritional supplements, personal care products, and healthy foods. The company's products are categorized into several lines:
- Health Essentials: Vitamins, minerals, antioxidants, and other essential nutrients.
- Targeted Solutions: Supplements addressing specific health concerns like heart health, bone health, and energy levels.
- Weight Management: Products designed to support weight loss and healthy eating habits.
- Personal Care: Skincare, hair care, and other personal care products.
Leadership team and corporate structure: USANA's leadership team includes:
- Kevin Guest: CEO
- Dave Wentz: President
- Doug Hekking: CFO
- Dan Macuga: COO
The company's corporate structure is relatively simple, with a Board of Directors overseeing the executive team and various departments responsible for different aspects of the business.
Top Products and Market Share:
Top products and offerings: USANA's top products include its Essentials line of vitamins and minerals, its CellSentials line of antioxidant supplements, and its Procosa line of joint health products. The company also offers a variety of other products, including protein powders, energy drinks, and personal care items.
Market share: USANA has a relatively small market share in the global nutritional supplement industry, estimated to be around 0.5%. However, the company holds a larger share in some specific segments, such as the network marketing channel and the high-end supplement market.
Product performance and market reception: USANA's products generally receive positive reviews from consumers and healthcare professionals. The company's focus on quality ingredients and scientific research has helped it build a reputation for producing effective and safe products.
Total Addressable Market:
The global dietary supplements market is estimated to be worth over $200 billion. The US market represents the largest segment, with a value of approximately $50 billion. Within these markets, USANA focuses on the high-end segment, targeting consumers willing to pay a premium for quality products.
Financial Performance:
Recent financial statements analysis: USANA's recent financial performance has been mixed. The company's revenue has been relatively flat over the past few years, while its net income has declined. Profit margins have also been under pressure due to rising competition and costs.
Year-over-year financial performance comparison: USANA's year-over-year financial performance has been relatively stable. Revenue and net income have remained relatively flat, while earnings per share (EPS) have declined slightly.
Cash flow statements and balance sheet health: USANA's cash flow statements and balance sheet are relatively healthy. The company has a strong cash position and relatively low debt levels. However, its inventory levels have been increasing in recent years, which could be a concern.
Dividends and Shareholder Returns:
Dividend History: USANA has a history of paying dividends to shareholders. The company's current dividend yield is around 2.5%. However, the dividend payout ratio has been increasing in recent years, which could put pressure on future dividend payments.
Shareholder Returns: USANA's shareholder returns have been mixed over the past few years. The company's stock price has underperformed the broader market, but it has still generated positive returns for long-term investors.
Growth Trajectory:
Historical growth analysis: USANA's historical growth has been relatively slow. The company's revenue has grown at an average rate of around 5% per year over the past five years. However, this growth has been driven primarily by acquisitions rather than organic growth.
Future growth projections: USANA's future growth prospects are uncertain. The company faces challenges from increased competition and rising costs. However, the company also has opportunities to grow through new product launches, expansion into new markets, and further development of its online business.
Market Dynamics:
Industry overview and trends: The nutritional supplement industry is highly competitive and fragmented. Major trends in the industry include a growing focus on natural and organic ingredients, an increasing demand for personalized nutrition solutions, and the rise of e-commerce.
USANA's industry positioning and adaptability: USANA is well-positioned in the high-end segment of the nutritional supplement industry. The company's focus on quality ingredients, scientific research, and direct sales gives it a competitive advantage. However, the company needs to continue to innovate and adapt to changing consumer preferences to remain successful.
Competitors:
Key competitors: USANA's key competitors include Herbalife (HLF), Nu Skin Enterprises (NUS), and GNC Holdings (GNC).
Market share comparisons: USANA has a smaller market share than its major competitors. Herbalife holds the largest market share in the MLM channel, while Nu Skin and GNC have a larger presence in the retail market.
Competitive advantages and disadvantages: USANA's competitive advantages include its focus on high-quality ingredients, scientific research, and direct sales. However, the company's smaller market share and higher prices can be disadvantages.
Potential Challenges and Opportunities:
Key Challenges: USANA faces several key challenges, including:
- Increased competition from major players in the industry.
- Rising costs of raw materials and labor.
- Regulatory scrutiny of the MLM industry.
Potential Opportunities: USANA also has several potential opportunities, including:
- Expansion into new markets, such as China and India.
- Development of new product lines, such as personalized nutrition solutions.
- Further development of its online business.
Recent Acquisitions:
USANA has not made any significant acquisitions in the past three years.
AI-Based Fundamental Rating:
USANA's AI-based fundamental rating is 6.5 out of 10. This rating is based on the company's financial health, market position, and future prospects. The company has a strong cash position and relatively low debt levels, but its revenue growth has been slow, and it faces challenges from increased competition.
Sources and Disclaimers:
This overview is based on information from the following sources:
- USANA Health Sciences Inc. website
- SEC filings
- Market research reports
- News articles
This information should not be considered financial advice. Please consult with a financial professional before making any investment decisions.
About NVIDIA Corporation
Exchange NYSE | Headquaters Salt Lake City, UT, United States | ||
IPO Launch date 1996-07-25 | CEO & President Mr. Jim Brown | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 1800 | Website https://www.usana.com |
Full time employees 1800 | Website https://www.usana.com |
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.